References
Dequeker, J., Van de Venne, H. (editors). Proceedings Symposium Auranofin. Clin Rheumatol, 1984, 3, Suppl. n∘ 1.
Kvien, T.K., Høyeraal, H.M., Kåss, E. Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies. Scand J Rheumatol, 1982, 11, 187–192.
Kvien, T.K., Høyeraal, H.M., Sandstad, B. Assessment methods of disease activity in juvenile rheumatoid arthritis — evaluated in a prednisolone/ placebo double-blind study. J Rheumatol, 1982, 9, 696–702.
Giannini, E.H., Brewer, E.J., Person, D.A. Auranofin in the treatment of juvenile rheumatoid arthritis. J Pediatr, 1983, 102, 138–141.
Lewis, D., Capell, H.A., McNeil, C.J., Iqbal, M.S., Brown, D.H., Smith, W.E. Gold levels produced by treatment with auranofin and sodium aurothiomalate. Ann Rheum Dis, 1983, 42, 566–570.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kvien, T.K., Høyeraal, H.M., Sandstad, B. et al. Oral gold (auranofin) in juvenile rheumatoid arthritis: A 48-week phase II study. Clin Rheumatol 3, 551–552 (1984). https://doi.org/10.1007/BF02031282
Issue Date:
DOI: https://doi.org/10.1007/BF02031282